
Cyclopentolate HCL Mydriatics
| Product/Composition | Cyclopentolate HCL Mydriatics |
|---|---|
| Form | Mydriatics |
| Strength | 1% |
| Production Capacity | 1 Million Mydriatics/Month |
| Packaging | 5ml |
| Therapeutic use | Eye and Ear Drops |
| Package Insert/Leaflet | Available upon request |
Cyclopentolate Hydrochloride (HCl)
-
Type: Mydriatic and cycloplegic agent (anticholinergic)
-
Main Use: Temporarily dilates the pupil and paralyzes the eye’s focusing muscle (ciliary muscle).
How It Works
-
Cyclopentolate blocks acetylcholine receptors in the eye’s muscles.
-
This causes:
-
Mydriasis – pupil dilation (for examination or treatment)
-
Cycloplegia – relaxation of the ciliary muscle, preventing the eye from focusing (important for measuring refractive error in children).
-
Forms Available
-
Usually in eye drop form (commonly 0.5%, 1%, or 2% solutions).
Common Uses
-
Diagnostic purposes:
-
Eye examinations (fundus exams)
-
Refraction tests in children (to accurately measure vision prescription without interference from eye focusing)
-
-
Therapeutic purposes:
-
Treatment of iritis or uveitis (eye inflammation) to reduce pain and prevent adhesions
-
Pre- and post-surgical use to keep the pupil dilated when needed
-
Advantages
-
Shorter duration of action compared to some other mydriatics (like atropine), so recovery of normal vision is faster.
-
Effective for both pupil dilation and pain relief in inflammatory eye conditions.
Possible Side Effects
-
Eye-related:
-
Temporary blurred vision
-
Light sensitivity (photophobia)
-
Mild stinging on instillation
-
-
Systemic (rare):
-
Dry mouth, flushing, rapid heartbeat
-
Confusion or restlessness (more likely in children if absorbed too much)
-
Precautions
-
Wear sunglasses outdoors until the effect wears off (to protect from bright light).
-
Use with caution in infants, children, and elderly (risk of systemic side effects).
-
Avoid touching dropper tip to eye or skin to prevent contamination.
-
Effects usually wear off in 6–24 hours, but can last longer in some people.